Bayer Consumer Health is responding to increasing demand for menopause products with a new UK line under the Canesten brand.
Bayer Consumer Health Enters UK Menopause Category With CanesMeno
With its new CanesMeno range, Bayer Consumer Health wants to help the estimated 13m women in the UK who are currently perimenopausal or menopausal.
More from United Kingdom
• By
Maxwellia's “bold, honest, and completely unfiltered” campaign for Evana menstrual health brand tells the story of a woman dealing with the realities of a heavy period, showing “real blood, real leaks.”
• By
HBW Insight catches up with Maxwellia CEO Anna Maxwell to discuss her company's journey so far, and what she sees as the opportunities for Rx-to-OTC switch in UK women's health and beyond.
• By
Pirilieve Hayfever Relief Tablets contain 120mg fexofenadine hydrochloride, which the firm notes is an active ingredient that was “previously only available behind pharmacy counters.”
• By
Advercheck managing director James Walmsley talks to HBW Insight about the challenges facing consumer health companies today as they move away from the prescription medicines sector and its pipeline of switchable ingredients towards self-care and prevention.
More from Innovation & IP
• By
In its first health claim assessment of 2025, the European Commission has rejected an application by Sweden's Greenleaf for its Appethyl supplement.
• By
Biotech identifying and stabilizing RNA compounds that can be incorporated into dietary supplements will receive mentorship, strategy guidance and technical support from experts at Nestlé Health Science.
• By
With the acquisition of HKS Health Solutions, 1Q Health Group states its ambition to be the leading full-service CDMO in Europe. Separately, Italy's Ourvita enhances its capabilities through a deal for Poland's Laboratoria Natury.